These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 9476376

  • 1. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
    Wilczek H.
    Cas Lek Cesk; 1997 Dec 03; 136(23):730-2. PubMed ID: 9476376
    [Abstract] [Full Text] [Related]

  • 2. Beta-2-microglobulin in diseases with high bone remodeling.
    Ripoll E, Arribas I, Relea P, Varela L, Villa LF, Revilla M, Rico H.
    Calcif Tissue Int; 1995 Oct 03; 57(4):272-6. PubMed ID: 8673864
    [Abstract] [Full Text] [Related]

  • 3. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ, Yocono M, Raisz LG.
    Am J Med Sci; 1994 Oct 03; 308(4):226-33. PubMed ID: 7942981
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenously administered pamidronate in the treatment of Paget's disease of bone.
    Tucci JR, Bontha S.
    Endocr Pract; 2001 Oct 03; 7(6):423-9. PubMed ID: 11747277
    [Abstract] [Full Text] [Related]

  • 6. beta 2-Microglobulin in Paget's bone disease.
    Rico H, Ripoll E, Arribas I, Revilla M, Relea P, Villa LF, de Buergo MA.
    Calcif Tissue Int; 1994 May 03; 54(5):389-91. PubMed ID: 8062156
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Watts RA, Skingle SJ, Bhambhani MM, Pountain G, Crisp AJ.
    Ann Rheum Dis; 1993 Aug 03; 52(8):616-8. PubMed ID: 8215628
    [Abstract] [Full Text] [Related]

  • 8. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
    Montagnani A, Gonnelli S, Cepollaro C, Campagna MS, Franci MB, Pacini S, Gennari C.
    Bone; 2003 Jan 03; 32(1):15-9. PubMed ID: 12584031
    [Abstract] [Full Text] [Related]

  • 9. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA, Altayar O, BenKhadra K, Qasim Agha OQ, Asi N, Nabhan M, Prokop LJ, Tebben P, Murad MH.
    Osteoporos Int; 2015 Jul 03; 26(7):1875-91. PubMed ID: 26037791
    [Abstract] [Full Text] [Related]

  • 10. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L, Peris P, Guañabens N, Vidal S, Ros I, Pons F, Filella X, Monegal A, Muñoz-Gomez J, Ballesta AM.
    Arthritis Rheum; 2003 Mar 03; 48(3):824-8. PubMed ID: 12632438
    [Abstract] [Full Text] [Related]

  • 11. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ, Boyce BF, Patel U, Jenkins A, Ralston SH, Boyle IT.
    Ann Rheum Dis; 1991 Dec 03; 50(12):930-3. PubMed ID: 1768163
    [Abstract] [Full Text] [Related]

  • 12. Paget's disease of the bone: a report of three cases.
    Bhatt K, Balakrishnan C, Mangat G, Bajan K, Ashavaid T, Joshi VR.
    J Assoc Physicians India; 2006 Jul 03; 54():571-4. PubMed ID: 17089908
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 03; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

  • 14. [Bisphosphonate therapy of Paget's disease of bone with pamidronate].
    Grauer A, Klar B, Knaus J, Scharla SH, Ziegler R.
    Med Klin (Munich); 1996 Jan 15; 91(1):14-9. PubMed ID: 8839196
    [Abstract] [Full Text] [Related]

  • 15. Paget's disease of bone: five regimens of pamidronate treatment.
    Pepersack T, Karmali R, Gillet C, François D, Fuss M.
    Clin Rheumatol; 1994 Mar 15; 13(1):39-44. PubMed ID: 8187442
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P, Delmas PD.
    J Clin Endocrinol Metab; 1993 Oct 15; 77(4):1046-53. PubMed ID: 8104954
    [Abstract] [Full Text] [Related]

  • 17. Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
    Patel S, Pearson D, Hosking DJ.
    Arthritis Rheum; 1995 Oct 15; 38(10):1506-12. PubMed ID: 7575701
    [Abstract] [Full Text] [Related]

  • 18. [What do we know about the significance of vitamin D in Paget's disease of the bone?].
    Wilczek H, Stĕpán J, Justová V.
    Cas Lek Cesk; 1995 Dec 13; 134(24):785-7. PubMed ID: 8599821
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
    Muschitz C, Feichtinger X, Haschka J, Kocijan R.
    Wien Med Wochenschr; 2017 Feb 13; 167(1-2):18-24. PubMed ID: 27600563
    [Abstract] [Full Text] [Related]

  • 20. High-dose pamidronate in the management of resistant Paget's disease.
    Cundy T, Wattie D, King AR.
    Calcif Tissue Int; 1996 Jan 13; 58(1):6-8. PubMed ID: 8825232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.